Search results
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 13 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Has Big AI News. Is the Stock a Buy?
The Motley Fool via AOL· 6 days agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 5 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 4 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Moderna’s long Covid plan
Politico· 4 days agoModerna is eyeing a new target: long Covid. The pharmaceutical company that became a household name when it developed a Covid-19 vaccine now wants to...
Selling US$3.3m Of Moderna Stock Rewarded Insiders
Simply Wall St. via Yahoo Finance· 7 days agoModerna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year are probably in a more...
US, European nations consider vaccinating workers exposed to bird flu
Reuters via Yahoo News· 23 hours agoThe United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 4 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...